Skip to content
La Clinique du Sommeil
La Clinique du Sommeil
All news
Clinical study

A study on esketamine and sleep after a cesarean section

A study examined the effect of a treatment containing esketamine on sleep quality, pain, and depressive symptoms in women with sleep disorders undergoing a cesarean section. The results show an improvement in sleep on the first day after the operation, but other results require further studies.

A study on esketamine and sleep after a cesarean section

Study background

Sleep disorders before a cesarean section can worsen pain after the operation and increase the risk of postpartum depression. Esketamine is known for its analgesic (pain-relieving) and antidepressant effects, but its impact on sleep in women with pre-existing sleep disorders is not well understood.

What the study found

The study included 90 women who were to undergo a cesarean section under general anesthesia. They were randomly assigned to receive either a treatment containing esketamine or standard treatment. The results show that those who received esketamine reported better sleep quality on the first day after the operation. However, the results regarding pain and depressive symptoms are less clear and require further research.

Implications for patients

For women with sleep disorders who are to undergo a cesarean section, this study suggests that a treatment containing esketamine could improve sleep quality immediately after the operation. However, it is important to note that other effects, such as pain management and depressive symptoms, have not been clearly established and require more in-depth studies.

This article is provided for information only and does not replace medical advice. For any question about your own situation, talk to your doctor.